Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

Completed

Conditions studied: Primary Progressive Multiple Sclerosis

In brief

The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow up questionnaire and blood/urine collection for a period of 5 years.

Key facts

Study ID

NCT01776060

Run by

Duke University

People needed

28

Starts

2013-01-01

Expected to finish

2020-09-21

Last updated by the study team

2024-05-21

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled in the MURDOCK Study Horizon 1.5 (Pro00011196)
• Enrolled in the Multiple Sclerosis Cohort (Pro00023791)
• Diagnosed with Primary Progressive Multiple Sclerosis
• At least 18 years of age

You may not qualify if…

• Participants not willing to participate or sign informed consent

Where it is running

• NE Neurology — Concord, North Carolina, United States
• The Stedman Center on the Duke Center for Living Campus — Durham, North Carolina, United States
• Raleigh Neurology Associates — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.